| Strategies targeting FLT3 beyond the kinase inhibitors MF Almatani, A Ali, S Onyemaechi, Y Zhao, L Gutierrez, VP Vaikari, ... Pharmacology & Therapeutics 225, 107844, 2021 | 15 | 2021 |
| Deletion of CD36 exhibits limited impact on normal hematopoiesis and the leukemia microenvironment Y Meng, M Pospiech, A Ali, R Chandwani, M Vergel, S Onyemaechi, ... Cellular & Molecular Biology Letters 28 (1), 45, 2023 | 10 | 2023 |
| Enhanced T cell activation and cytotoxicity against AML via targeted anti-CD99 nanoparticle treatment S Kadam, A Ali, M Pospiech, S Onyemaechi, Y Meng, K Dhuri, JA MacKay, ... Biomedicine & Pharmacotherapy 179, 117265, 2024 | | 2024 |
| Enhanced T cell activation and cytotoxicity against AML via targeted anti-CD99-A192 ScFv-ELP nanoparticle treatment S Kadam, A Ali, M Pospiech, S Onyemaechi, Y Meng, K Dhuri, A Mackay, ... Cancer Research 84 (6_Supplement), 2363-2363, 2024 | | 2024 |
| Functional characterization of the impact of CD36 deletion on normal hematopoiesis and the leukemia microenvironment Y Meng, M Pospiech, A Ali, R Chandwani, S Onyemaechi, G Yaghmour, ... Cancer Research 83 (7_Supplement), 1732-1732, 2023 | | 2023 |
